293 related articles for article (PubMed ID: 25622898)
1. Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase.
Jackson KW; Christiansen VJ; Yadav VR; Silasi-Mansat R; Lupu F; Awasthi V; Zhang RR; McKee PA
Neoplasia; 2015 Jan; 17(1):43-54. PubMed ID: 25622898
[TBL] [Abstract][Full Text] [Related]
2. Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
Christiansen VJ; Jackson KW; Lee KN; Downs TD; McKee PA
Neoplasia; 2013 Apr; 15(4):348-58. PubMed ID: 23555181
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein.
Dvořáková P; Bušek P; Knedlík T; Schimer J; Etrych T; Kostka L; Stollinová Šromová L; Šubr V; Šácha P; Šedo A; Konvalinka J
J Med Chem; 2017 Oct; 60(20):8385-8393. PubMed ID: 28953383
[TBL] [Abstract][Full Text] [Related]
4. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR
Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147
[TBL] [Abstract][Full Text] [Related]
5. Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase.
Poplawski SE; Lai JH; Li Y; Jin Z; Liu Y; Wu W; Wu Y; Zhou Y; Sudmeier JL; Sanford DG; Bachovchin WW
J Med Chem; 2013 May; 56(9):3467-77. PubMed ID: 23594271
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
Juillerat-Jeanneret L; Tafelmeyer P; Golshayan D
Expert Opin Ther Targets; 2017 Oct; 21(10):977-991. PubMed ID: 28829211
[TBL] [Abstract][Full Text] [Related]
7. Activatable bispecific liposomes bearing fibroblast activation protein directed single chain fragment/Trastuzumab deliver encapsulated cargo into the nuclei of tumor cells and the tumor microenvironment simultaneously.
Tansi FL; Rüger R; Böhm C; Steiniger F; Kontermann RE; Teichgraeber UK; Fahr A; Hilger I
Acta Biomater; 2017 May; 54():281-293. PubMed ID: 28347861
[TBL] [Abstract][Full Text] [Related]
8. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.
Brennen WN; Rosen DM; Wang H; Isaacs JT; Denmeade SR
J Natl Cancer Inst; 2012 Sep; 104(17):1320-34. PubMed ID: 22911669
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies.
Kelly T; Huang Y; Simms AE; Mazur A
Int Rev Cell Mol Biol; 2012; 297():83-116. PubMed ID: 22608558
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast activation protein: A potential therapeutic target in cancer.
Liu R; Li H; Liu L; Yu J; Ren X
Cancer Biol Ther; 2012 Feb; 13(3):123-9. PubMed ID: 22236832
[TBL] [Abstract][Full Text] [Related]
11. A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice.
Fang J; Xiao L; Joo KI; Liu Y; Zhang C; Liu S; Conti PS; Li Z; Wang P
Int J Cancer; 2016 Feb; 138(4):1013-23. PubMed ID: 26334777
[TBL] [Abstract][Full Text] [Related]
12. Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.
Plescia J; De Cesco S; Patrascu MB; Kurian J; Di Trani J; Dufresne C; Wahba AS; Janmamode N; Mittermaier AK; Moitessier N
J Med Chem; 2019 Sep; 62(17):7874-7884. PubMed ID: 31393718
[TBL] [Abstract][Full Text] [Related]
13. Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity.
Ryabtsova O; Jansen K; Van Goethem S; Joossens J; Cheng JD; Lambeir AM; De Meester I; Augustyns K; Van der Veken P
Bioorg Med Chem Lett; 2012 May; 22(10):3412-7. PubMed ID: 22525314
[TBL] [Abstract][Full Text] [Related]
14. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.
Santos AM; Jung J; Aziz N; Kissil JL; Puré E
J Clin Invest; 2009 Dec; 119(12):3613-25. PubMed ID: 19920354
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice.
Duperret EK; Trautz A; Ammons D; Perales-Puchalt A; Wise MC; Yan J; Reed C; Weiner DB
Clin Cancer Res; 2018 Mar; 24(5):1190-1201. PubMed ID: 29269377
[No Abstract] [Full Text] [Related]
16. The application of the fibroblast activation protein α-targeted immunotherapy strategy.
Jiang GM; Xu W; Du J; Zhang KS; Zhang QG; Wang XW; Liu ZG; Liu SQ; Xie WY; Liu HF; Liu JS; Wu BP
Oncotarget; 2016 May; 7(22):33472-82. PubMed ID: 26985769
[TBL] [Abstract][Full Text] [Related]
17. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy.
Brennen WN; Isaacs JT; Denmeade SR
Mol Cancer Ther; 2012 Feb; 11(2):257-66. PubMed ID: 22323494
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
Huber MA; Kraut N; Park JE; Schubert RD; Rettig WJ; Peter RU; Garin-Chesa P
J Invest Dermatol; 2003 Feb; 120(2):182-8. PubMed ID: 12542520
[TBL] [Abstract][Full Text] [Related]
19. On the edge of validation--cancer protease fibroblast activation protein.
Wolf BB; Quan C; Tran T; Wiesmann C; Sutherlin D
Mini Rev Med Chem; 2008 Jun; 8(7):719-27. PubMed ID: 18537727
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).
Zi F; He J; He D; Li Y; Yang L; Cai Z
Mol Med Rep; 2015 May; 11(5):3203-11. PubMed ID: 25593080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
